Stephen I. Pelton, MD
Professor
Boston University School of Medicine
Dept of Pediatrics
Infectious Diseases

MD, State University of New York at Buffalo




Stephen I Pelton MD is Professor of Pediatrics and Epidemiology at Boston University School of Medicine and Public Health and Director of Pediatrics Infectious Diseases at Boston Medical Center. Dr Pelton's interests focus on the effects of recurrent disease and the long term effects of HIV, Hepatitis C and B, and Herpes among other things. Additionally, he organizes numerous clinical trials to discover new approaches to HIV prevention and treatment.

Director (Section) of Pediatrics>Infectious Disease
Boston University School of Medicine
Pediatrics
Infectious Diseases

Member
Boston University
Pulmonary Center


Professor
Boston University School of Public Health
Epidemiology




Proposal to evaluate prevalence, serotype distribution and density of pneumococcal nasopharyngeal colonization in children and parents
12/15/2015 - 03/31/2019 (PI)
Pfizer, Inc.


Acute Otitis Media (AOM) Study
08/01/2015 - 12/31/2018 (PI)
Pfizer, Inc.


Defining the new equilibrium of pneumococcal nasopharyngeal colonization following introduction of PCV13
01/01/2013 - 06/30/2017 (PI)
Merck, Sharp & Dohme Corp


Enhanced Surveillance for IPD in Massachusetts Children
01/01/2007 - 06/30/2017 (PI)
Wyeth Pharmaceuticals


Continued Surveillance of IPD in Children Less than 18 Years Old in Massachusetts in 2010-2012 (Impact of the Introduction of PCV13)
11/15/2010 - 11/14/2013 (PI)
Pfizer, Inc.


Carriage Prevalence of NTHi in Mother and Infant Dyads
11/01/2008 - 07/22/2011 (PI)
GlaxoSmithKline LLC


Pedi ID Fellow: International Fellowship in Vaccine Preventable Diseases
05/01/2008 - 04/30/2010 (PI)
Wyeth Pharmaceuticals

Enhanced Surveillance for Meningococcal Disease
04/07/2005 - 04/06/2008 (PI)
Sanofi-Pasteur, SA

NTHi LPS: Virulence Factor and Vaccine Candidate
08/01/2003 - 07/31/2007 (Co-PI)
NIH/National Institute on Deafness & Communication Disorders
5 R01 DC05855 03

Identification of Children with Invasive Pneumococcal Disease in Massachusetts and Immunologic Evaluation of Vaccine Failures
10/01/2001 - 06/30/2005 (PI)
Wyeth-Lederle

Showing 10 of 20 results. Show All Results

Surveillance of Pneumococcal Colonization in Children less t
10/15/2021 - 08/14/2026 (PI)
Pfizer, Inc

Pneumonia Biology
01/11/2017 - 12/31/2023 (PI)
Trustees of Boston University NIH-NHLBI

A Prospective Observational Study to Evaluate the Safety of COVID-19 Vaccination in Pregnant Women
12/01/2020 - 11/30/2023 (PI)
Centers for Disease Control and Prevention/DHHS

SARS-CoV-2 disruption of Nasopharyngeal Microbiome: Impact o
04/08/2021 - 06/30/2023 (PI)
Merck

IMPAACT 2017 – Phase I/II Study of the Safety, Acceptability, Tolerability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Long-Acting Injectable Rilpivirine in Virologically Suppressed HIV-Infected Children and Adolescents
01/01/2019 - 12/31/2022 (PI)
Johns Hopkins University National Institute o

Safety of Recombinant Influenza Vaccine(Flublok) in Pregnant Women
09/15/2018 - 10/28/2022 (PI)
CDC

Interactions of Streptococcus pneumoniae and Non-typeable Haemophilus influenzae and the developm…
10/01/2017 - 07/31/2022 (PI)
Merck

Ryan White Title IV Women, Infant, Children, Youth and Affec
08/01/2012 - 07/31/2022 (PI)
HIV/AIDS Bureau/HRSA/DHHS

Sanofi NTHi Vaccine Program-Pelton Lab Collaboration
02/03/2021 - 03/31/2022 (PI)
Sanofi Pasteur

Surveillance of Invasive Pneumococcal Diseases (IPD) in Massachusetts’ Children - WI245928
12/13/2018 - 03/31/2022 (PI)
Pfizer, Inc

Showing 10 of 72 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs
2016 Single Antigen Strategy for Prevention of Recurrent and Chronic Suppurative Otitis 5R21DC014323-02
2015 Single Antigen Strategy for Prevention of Recurrent and Chronic Suppurative Otitis 1R21DC014323-01A1
2007 RANDOMIZED TRIAL OF THE SAFETY AND IMMUNOGENICITY OF FLUMIST IN HIV INF CHILDREN 2M01RR000533-39-8164 503
2007 SAFETY AND IMMUNOGENICITY STUDY OF QUADRIVALENT HUMAN PAPILLOMAVIRUS 2M01RR000533-39-8202 503
2007 LATE OUTCOMES OF PEDIATRIC HIV INFECTION (PACTG 219C VERSION 40) 2M01RR000533-39-8205 503
2006 RANDOMIZED TRIAL OF THE SAFETY AND IMMUNOGENICITY OF FLUMIST IN HIV INF CHILDREN 5M01RR000533-38-5614 503
2006 IMMUNOGENICITY OF LIVE ATTENUATED VARICELLA VACCINE HIV INFECTED CHILDREN 5M01RR000533-38-5632 503
2006 LATE OUTCOMES OF PEDIATRIC HIV INFECTION (PACTG 219C VERSION 40) 5M01RR000533-38-5633 503
2006 ULTRASOUND EVAL OF FLOW RELATED ARTERIAL DILATION IN HIV INFECTED CHILDREN 5M01RR000533-38-5588 503
2005 ULTRASOUND EVAL OF FLOW RELATED ARTERIAL DILATION IN HIV INFECTED CHILDREN 5M01RR000533-37-5428 503
Showing 10 of 46 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Duarte G, Muresan P, Ward S, Laimon L, Pelton SI, Canniff J, Golner A, Bone F, Newton L, Fenton T, Coutinho CM, João EC, Santos BR, Pilotto JH, Oliveira RH, Pinto JA, Machado ES, Kreitchman R, Chakhtoura N, Mussi-Pinhata MM, Weinberg A. Immunogenicity of Conjugated and Polysaccharide Pneumococcal Vaccines Administered During Pregnancy or Postpartum to Women With HIV. J Infect Dis. 2022 03 15; 225(6):1021-1031. PMID: 34791324; PMCID: PMC8921998; DOI: 10.1093/infdis/jiab567;
     
  2. Mussi-Pinhata MM, Ward S, Laimon L, Pelton SI, Canniff J, Golner A, Bone F, Newton L, Muresan P, Fenton T, Johnson MJ, João EC, Santos BR, Pilotto JH, Oliveira RH, Pinto JA, Dal Bó AGBL, Kreitchmann R, Chakhtoura N, Duarte G, Weinberg A. Effect of Maternal Vaccination of PCV-10, PPV-23 or Placebo on the Immunogenicity of PCV-10 in HIV-exposed Uninfected Infants: A Randomized Clinical Trial. Clin Infect Dis. 2022 Jan 17. PMID: 35037049
     
  3. Patel SM, Shaik-Dasthagirisaheb YB, Congdon M, Young RR, Patel MZ, Mazhani T, Boiditswe S, Leburu T, Lechiile K, Arscott-Mills T, Steenhoff AP, Feemster KA, Shah SS, Cunningham CK, Pelton SI, Kelly MS. Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine. PLoS One. 2022; 17(1):e0262225. PMID: 34986196; PMCID: PMC8730465; DOI: 10.1371/journal.pone.0262225;
     
  4. Divino V, Ruthwik Anupindi V, DeKoven M, Mould-Quevedo J, Pelton SI, Postma MJ, Levin MJ. A Real-World Clinical and Economic Analysis of Cell-Derived Quadrivalent Influenza Vaccine Compared to Standard Egg-Derived Quadrivalent Influenza Vaccines During the 2019-2020 Influenza Season in the United States. Open Forum Infect Dis. 2022 Jan; 9(1):ofab604. PMID: 35028334; PMCID: PMC8753033; DOI: 10.1093/ofid/ofab604;
     
  5. Ragan EJ, McCallum C, Marathe J, Cole M, Hofman M, Henderson AJ, Flack T, Miller NS, Burks EJ, Zhao GQ, Denis R, Lin NH, Jacobson KR, Andry CD, Pelton SI, Duffy ER, Bhadelia N. Pandemic Response Requires Research Samples: A U.S. Safety-Net Hospital's Experience and Call for National Action. Ann Intern Med. 2021 12; 174(12):1727-1732.View Related Profiles. PMID: 34724402; DOI: 10.7326/M21-2857;
     
  6. Lapidot R, Vietri J, Shaff M, Averin A, Lonshteyn A, Weycker D, Wasserman M, Farkouh R, Pelton SI. Community-acquired pneumonia in infants: Not simply an acute event with complete recovery. Respir Med. 2022 01; 191:106671.View Related Profiles. PMID: 34864372
     
  7. Levin MJ, Divino V, Shah D, DeKoven M, Mould-Quevedo J, Pelton SI, Postma MJ. Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged = 65 Years in the US during the 2019-20 Influenza Season-A Retrospective Cohort Analysis. Vaccines (Basel). 2021 Oct 08; 9(10). PMID: 34696254; PMCID: PMC8540032; DOI: 10.3390/vaccines9101146;
     
  8. Epstein RL, Moloney C, Garfinkel J, Saia K, Wachman EM, Lodi S, Pelton SI. Enhancing Linkage to Hepatitis C Virus Treatment Following Pregnancy in Women Identified During Perinatal Care. Hepatol Commun. 2021 Sep; 5(9):1543-1554.View Related Profiles. PMID: 34510828; PMCID: PMC8435278; DOI: 10.1002/hep4.1748;
     
  9. Pelton SI, Lapidot R. Inferring Public Health Policies From Epidemiology and Whole Genome Sequencing of Invasive Pneumococcal Isolates From a Surveillance Network. Clin Infect Dis. 2021 06 15; 72(12):e957-e958.View Related Profiles. PMID: 33151276
     
  10. Averin A, Shaff M, Weycker D, Lonshteyn A, Sato R, Pelton SI. Mortality and readmission in the year following hospitalization for pneumonia among US adults. Respir Med. 2021 Aug-Sep; 185:106476. PMID: 34087608
     
Showing 10 of 300 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 289 publications over 40 distinct years, with a maximum of 15 publications in 2010

YearPublications
19803
19813
19832
19842
19855
19885
19894
19903
19913
19925
19937
19944
19957
19963
19972
19984
199911
200011
20014
200211
20039
20044
200511
20066
20077
20089
200914
201015
201112
201213
201312
201414
20159
20166
201710
20186
20199
20208
202113
20223
Contact for Mentoring:

670 Albany St Biosquare III
Boston MA 02118
Google Map


Pelton's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department